Clinical trial
Effectiveness of XCell on Autolytic Debridement of Venous Ulcers
NCT00446823 · Xylos Corporation, Industry · Completed
Key facts
| NCT number | NCT00446823 |
|---|---|
| Title | Effectiveness of XCell on Autolytic Debridement of Venous Ulcers |
| Official title | A Prospective, Randomized, Controlled Clinical Study to Evaluate the Effectiveness of a Cellulose Matrix Wound Dressing for Autolytic Debridement and Healing of Chronic Venous Ulcers |
| Acronym | XCell |
| Lead sponsor | Xylos Corporation, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Venous Ulcer |
| Intervention type | Device |
| Interventions | XCell cellulose wound dressing, Impregnated gauze dressing |
| Enrollment | 50 |
| Start date | Jun 1, 2002 |
| Completion | Dec 1, 2003 |
| First posted | Mar 13, 2007 |
| Last update posted | Mar 13, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: